PRESS RELEASE
News
-
-
PRESS RELEASE
Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies
Dermapharm Holding SE reports 7.3% rise in unadjusted EBITDA to EUR 147.0 million, driven by organic growth in branded pharmaceuticals segment. High-revenue expected in H2. Full report at https://ir.dermapharm.de/en -
PRESS RELEASE
Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 published in JITC
Transgene announces preclinical proof-of-concept data of oncolytic virus TG6050 published in JITC, showcasing tumor regression and immune remodeling capabilities without systemic toxicity. TG6050 progressing in Phase I trial for NSCLC -
-
-
-
-
-
-
REGULATED PRESS RELEASE
Neoen lance la construction de la 2ème tranche de Western Downs Battery en Australie après avoir signé un contrat de batterie virtuelle de 200 MW avec AGL Energy
Neoen lance la construction de la 2ème tranche de Western Downs Battery en Australie, en partenariat avec AGL Energy, pour fournir une capacité de stockage de 200 MW dans le Queensland
